Report Overview

Asia Pacific Stem Cell Therapy Market – Industry Trends & Forecast Report, 2030

Asia Pacific Stem Cell Therapy Market size was estimated at USD 2.76 billion in 2023. During the forecast period between 2024 and 2029, the size of Asia Pacific Stem Cell Therapy Market is projected to grow at a CAGR of 10.48% reaching a value of USD 5.02 billion by 2030. The Asia Pacific Stem Cell Therapy Market is primarily driven by increasing investments in research and development of stem cell therapies for the treatment of rising prevalence of chronic diseases and growing awareness about the therapeutic potential of stem cells. Advancements in healthcare infrastructure, a surge in government initiatives, and the expanding elderly population contribute to market growth. Additionally, collaborations between research institutions and pharmaceutical companies, coupled with favorable regulatory frameworks, propel the adoption of stem cell therapies. The region's robust biotechnology sector and the pursuit of innovative treatment options further stimulate market expansion, fostering a conducive environment for advancements in stem cell therapy across diverse medical applications.

Stem Cell Therapy – Overview

Stem cell therapy involves using undifferentiated cells to treat or prevent diseases. These versatile cells have the unique ability to develop into various specialized cell types, promoting tissue repair and regeneration. Derived from embryos, adult tissues, or induced pluripotent stem cells, they offer promising potential for treating conditions like heart disease, neurological disorders, and injuries. Stem cell therapy aims to harness the body's natural healing abilities, advancing medical interventions by replacing damaged cells and tissues. While research is ongoing, ethical considerations and regulatory challenges underscore the need for careful exploration and application of this groundbreaking medical approach.

Asia Pacific Stem Cell Therapy Market

Growth Drivers

Escalating Chronic Disease Cases

The relentless surge in chronic diseases across Asia Pacific spurs the increasing need for innovative stem cell therapies. As the region grapples with an increasing burden of ailments, stem cell therapy emerges as a beacon of hope. With its potential to revolutionize treatment modalities, the Asia Pacific Stem Cell Therapy Market witnesses unprecedented growth, offering a lifeline to patients and transforming the healthcare landscape.

Challenges

Soaring Costs Could Deny Access to Stem Cell Therapies for Large Population across Asia Pacific

The Asia Pacific Stem Cell Therapy Market faces a critical challenge due to the high cost of stem cell therapy. The exorbitant costs associated with innovative medical treatment create a significant barrier to access. Affordability becomes a major concern, limiting the widespread adoption of stem cell therapy and hindering its potential impact on healthcare outcomes in the region. The financial restraint raises questions about equitable healthcare access and underscores the need for measures to address the soaring costs.

Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market

On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. In response to this global health crisis, researchers have been actively pursuing innovative cures and treatments. Recent years have demonstrated the efficacy of stem cell therapy in treating respiratory conditions, particularly COVID-19. The official international registry for clinical trials has recorded at least 10 projects focused on utilizing mesenchymal stem cells to treat patients with coronavirus pneumonia. The surge in research and clinical trials has led to an increased demand for stem cell therapy, consequently boosting the sales of stem cell therapy treatments.

Impact of Escalating Geopolitical Tensions on Asia Pacific Stem Cell Therapy Market

Escalating geopolitical tensions in the Asia Pacific region have significant repercussions on the Stem Cell Therapy Market. Heightened uncertainties disrupt supply chains, hampering research and development efforts. For instance, territorial disputes involving China and its neighbors have led to economic uncertainties impacting investment in the sector. Additionally, the Russia-Ukraine war exacerbates challenges, with potential disruptions in the supply of raw materials and increased market volatility. The Asia Pacific Stem Cell Therapy Market faces a daunting landscape, grappling with geopolitical intricacies that threaten research continuity, collaboration, and investment flow, ultimately impeding the market's growth and innovation.

Asia Pacific Stem Cell Therapy Market

Segmental Coverage

Asia Pacific Stem Cell Therapy Market – By Type

Based on type, Asia Pacific Stem Cell Therapy Market is divided into Autologous and Allogeneic segments. Autologous stem cell therapy involves using a patient's cells for treatment, offering personalized and efficient solutions. The segment's prominence reflects the region's growing focus on personalized medicine and the potential for enhanced therapeutic outcomes through patient-specific treatments. Allogeneic stem cell therapy, which uses cells from a donor, also contributes to the market, catering to specific medical needs. However, the dominance of the autologous segment underscores the demand for tailored healthcare solutions in the Asia Pacific region.

Asia Pacific Stem Cell Therapy Market – By Cell Source

By cell source, Asia Pacific Stem Cell Therapy Market is divided into Adipose Tissue-Derived, MSC, Bone Marrow, and Placenta/Umbilical Cord segments. The mesenchymal stem cells (MSC) segment is the largest cell source in the Asia Pacific Stem Cell Therapy Market. MSCs have gained prominence due to their versatility in differentiation and therapeutic applications, contributing significantly to the region's stem cell therapy market. With widespread research and clinical applications, MSCs stand out as the leading segment, reflecting their pivotal role in advancing regenerative medicine across diverse medical fields in the Asia Pacific region.

Asia Pacific Stem Cell Therapy Market – By Application

Based on application, Asia Pacific Stem Cell Therapy Market is divided into Musculoskeletal, Wounds, Surgeries, Cardiovascular, and Neurological segments. Musculoskeletal application dominates the market, reflecting a significant focus on addressing orthopedic and musculoskeletal disorders through stem cell therapies. The segment underscores the region's emphasis on enhancing treatments for conditions related to bones, joints, and muscles, contributing to advancements in regenerative medicine and healthcare. The growing demand for innovative solutions in musculoskeletal applications signals a noteworthy trend in the Asia Pacific Stem Cell Therapy Market, positioning it as a key player in the global landscape.

Asia Pacific Stem Cell Therapy Market – By End user

By end user, Asia Pacific Stem Cell Therapy Market is divided into Hospitals & Clinics, and Academic & Research Institutes segments. The hospitals & clinics segment stands out as the larger segment, reflecting the significant adoption of stem cell therapy in medical settings. The dominance is attributed to the increasing awareness and acceptance of stem cell treatments for various medical conditions, emphasizing the pivotal role of healthcare institutions in driving the growth of stem cell therapy across the Asia Pacific region.

Asia Pacific Stem Cell Therapy Market – By Country

Based on country, Asia Pacific Stem Cell Therapy Market is divided into China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, and Rest of APAC. China stands out as the largest segment, showcasing significant growth and dominance in stem cell therapy. The country's robust research initiatives, increasing healthcare investments, and a rapidly aging population contribute to its prominence in advancing stem cell technologies and applications. China's leadership in the market highlights its pivotal role in shaping the overall landscape of stem cell therapy in the Asia Pacific region.

Competitive Landscape

Major players in the Asia Pacific Stem Cell Therapy Market include Bristol Myers Squibb Company, Gilead Sciences Inc, JCR Pharmaceuticals Co Ltd, Kolon TissueGene Inc, MEDIPOST Co Ltd, Smith & Nephew Plc, Vericel Corporation, Takeda Pharmaceutical Company Limited, Mesoblast Ltd. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Asia Pacific Stem Cell Therapy Market.

Recent Developments

• In September 2020 - MEDIPOST initiated the Phase 2 clinical trial of CARTISTEM, an allogenic stem cell therapy product for knee osteoarthritis, in Japan.

​​​​​​​Scope of Report

By Type

• Autologous

• Allogeneic

By Cell Source

• Adipose Tissue-Derived

• MSC

• Bone Marrow

• Placenta/Umbilical Cord

By Application

• Musculoskeletal

• Wounds

• Surgeries

• Cardiovascular

• Neurological

By End User

• Hospitals & Clinics

• Academic & Research Institutes

By Country

• China

• India

• Japan

• South Korea

• Australia & New Zealand

• Indonesia

• Malaysia

• Singapore

• Vietnam

• Rest of APAC

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3. Asia Pacific Stem Cell Therapy Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Rising prevalence of chronic diseases
         2. Growing awareness of stem cell therapy
      2. Restraints
         1. High cost of stem cell therapy
         2. Lack of regulation and standardization:
      3. Opportunities
         1. Development of personalized stem cell therapies:
         2. Expansion into new therapeutic areas:
      4. Challenges
         1. Limited clinical data:
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. Asia Pacific Stem Cell Therapy Market Overview
   1. Market Size & Forecast by Value & Volume, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
         1. Autologous
         2. Allogeneic
      2. By Cell Source
         1. Adipose Tissue-Derived
         2.  MSC
         3. Bone Marrow
         4.  Placenta/Umbilical Cord
      3. By Application
         1. Musculoskeletal
         2.  Wounds
         3. Surgeries
         4.  Cardiovascular
         5. Neurological
      4. By End User
         1. Hospitals & Clinics
         2. Academic & Research Institutes
      5. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Australia & New Zealand
         6. Indonesia
         7. Malaysia
         8. Singapore
         9. Vietnam
         10. Rest of APAC
5. China Stem Cell Therapy Market Overview
   1. Market Size & Forecast by Value & Volume, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Application
      4. By End User
6. India Stem Cell Therapy Market Overview
   1. Market Size & Forecast by Value & Volume, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Application
      4. By End User
7. Japan Stem Cell Therapy Market Overview
   1. Market Size & Forecast by Value & Volume, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Application
      4. By End User
8. South Korea Stem Cell Therapy Market Overview
   1. Market Size & Forecast by Value & Volume, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Application
      4. By End User
9. Australia & New Zealand Stem Cell Therapy Market Overview
   1. Market Size & Forecast by Value & Volume, 2019–2030
      1. By Value (USD Billion)
   2. Market Share & Forecast
      1. By Type
      2. By Cell Source
      3. By Application
      4. By End User
10. Indonesia Stem Cell Therapy Market Overview
    1. Market Size & Forecast by Value & Volume, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Application
       4. By End User
11. Malaysia Stem Cell Therapy Market Overview
    1. Market Size & Forecast by Value & Volume, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Application
       4. By End User
12. Singapore Stem Cell Therapy Market Overview
    1. Market Size & Forecast by Value & Volume, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Application
       4. By End User
13. Vietnam Stem Cell Therapy Market Overview
    1. Market Size & Forecast by Value & Volume, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Application
       4. By End User
14. Rest of APAC Stem Cell Therapy Market Overview
    1. Market Size & Forecast by Value & Volume, 2019–2030
       1. By Value (USD Billion)
    2. Market Share & Forecast
       1. By Type
       2. By Cell Source
       3. By Application
       4. By End User
15. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Asia Pacific Stem Cell Therapy Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
16. Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market
17. Impact of Escalating Geopolitical Tensions on Asia Pacific Stem Cell Therapy Market
18. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Bristol Myers Squibb Company
    2. Gilead Sciences Inc
    3. JCR Pharmaceuticals Co Ltd,
    4. Kolon TissueGene Inc
    5. MEDIPOST Co Ltd,
    6. Smith & Nephew Plc,
    7. Vericel Corporation
    8. Takeda Pharmaceutical Company Limited
    9. Mesoblast Ltd
    10. Other Prominent Players
19. Key Strategic Recommendations
20. Research Methodology
    1. Qualitative Research
       1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
       1. Secondary Research
       2. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation

*Financial information of non-listed companies will be provided as per availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

Figure 1      Asia Pacific Stem Cell Therapy Market Segmentation

Figure 2      Asia Pacific Stem Cell Therapy Market Value Chain Analysis

Figure 3      Company Market Share Analysis, 2023

Figure 4      Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 5      Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 6      Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 7      Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 8      Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 9      Asia Pacific Stem Cell Therapy Market Share, By Country, By Value, 2019–2030

Figure 10    China Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 11    China Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 12    China Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 13    China Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 14    China Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 15    India Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 16    India Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 17    India Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 18    India Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 19    India Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 20    Japan Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 21    Japan Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 22    Japan Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 23    Japan Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 24    Japan Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 25    South Korea Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 26    South Korea Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 27    South Korea Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 28    South Korea Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 29    South Korea Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 30    Australia & New Zealand Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 31    Australia & New Zealand Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 32    Australia & New Zealand Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 33    Australia & New Zealand Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 34    Australia & New Zealand Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 35    Indonesia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 36    Indonesia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 37    Indonesia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 38    Indonesia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 39    Indonesia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 40    Malaysia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 41    Malaysia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 42    Malaysia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 43    Malaysia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 44    Malaysia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 45    Singapore Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 46    Singapore Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 47    Singapore Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 48    Singapore Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 49    Singapore Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 50    Vietnam Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 51    Vietnam Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 52    Vietnam Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 53    Vietnam Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 54    Vietnam Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

Figure 55    Rest of Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 56    Rest of Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030

Figure 57    Rest of Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030

Figure 58     Rest of Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030

Figure 59    Rest of Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030

List of Tables

Table 1      Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 2      Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 3      Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 4      Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 5      Asia Pacific Stem Cell Therapy Market Size, By Country, By Value, 2019–2030

Table 6      China Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 7      China Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 8      China Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 9      China Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 10    India Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 11    India Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 12    India Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 13    India Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 14    Japan Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 15    Japan Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 16    Japan Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 17    Japan Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 18    South Korea Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 19    South Korea Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 20    South Korea Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 21    South Korea Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 22    Australia & New Zealand Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 23    Australia & New Zealand Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 24    Australia & New Zealand Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 25    Australia & New Zealand Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 26    Indonesia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 27    Indonesia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 28    Indonesia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 29    Indonesia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 30    Malaysia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 31    Malaysia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 32    Malaysia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 33    Malaysia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 34    Singapore Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 35    Singapore Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 36    Singapore Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 37    Singapore Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 38    Vietnam Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 39    Vietnam Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 40    Vietnam Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 41    Vietnam Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 42    Rest of Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030

Table 43    Rest of Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030

Table 44    Rest of Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030

Table 45    Rest of Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030

Table 46    Bristol Myers Squibb Company: Company Overview

Table 47    Bristol Myers Squibb Company Financial Overview

Table 48    Gilead Sciences Inc Company Overview

Table 49    Gilead Sciences Inc Financial Overview

Table 50    JCR Pharmaceuticals Co Ltd, Company Overview

Table 51    JCR Pharmaceuticals Co Ltd, Financial Overview

Table 52    Kolon TissueGene Inc Company Overview

Table 53    Kolon TissueGene Inc Financial Overview

Table 54    MEDIPOST Co Ltd, Company Overview

Table 55    MEDIPOST Co Ltd, Financial Overview

Table 56    Smith & Nephew Plc, Company Overview

Table 57    Smith & Nephew Plc, Financial Overview

Table 58    Vericel Corporation Company Overview

Table 59    Vericel Corporation Financial Overview

Table 60    Takeda Pharmaceutical Company Limited Company Overview

Table 61    Takeda Pharmaceutical Company Limited Financial Overview

Table 62    Mesoblast Ltd Company Overview

Table 63    Mesoblast Ltd Financial Overview